Home> Products> reliable blood sugar management

{ "products": [ { "_id": "668d24ff75f1701d34699e32", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLICLAGLAZE 80 ", "description": "GLICLAGLAZE 80 \nGliclazide (80mg)\nOverview\nGLICLAGLAZE 80 is an oral medication containing Gliclazide at a dosage of 80 mg. Gliclazide belongs to the class of drugs known as sulfonylureas and is primarily used to manage type 2 diabetes mellitus. It helps control blood sugar levels by stimulating the release of insulin from the pancreatic beta cells. GLICLAGLAZE 80 is an effective treatment option for individuals who require oral hypoglycemic therapy to maintain optimal blood glucose levels.\n\nBenefits of Gliclazide\n\nBlood Sugar Control\n\nGliclazide effectively lowers blood glucose levels by increasing insulin secretion.\nHelps prevent complications associated with diabetes, such as neuropathy, nephropathy, and retinopathy.\nReduced Risk of Hypoglycemia\n\nCompared to some other sulfonylureas, Gliclazide has a lower risk of causing hypoglycemia (low blood sugar levels).\nIt provides a balanced approach to managing blood sugar without causing excessive drops in glucose levels.\nCardiovascular Benefits\n\nStudies suggest that Gliclazide may have a protective effect on the cardiovascular system.\nIt may reduce the risk of cardiovascular events in diabetic patients, promoting overall heart health.\nImproved Glycemic Control\n\nHelps achieve and maintain target HbA1c levels, reflecting long-term glycemic control.\nCan be used in combination with other oral antidiabetic agents or insulin to enhance its effectiveness.\nUsage and Dosage\nGLICLAGLAZE 80 should be taken as prescribed by a healthcare professional. The typical starting dose is 40 to 80 mg daily, which can be adjusted based on the patient's blood glucose response. It is usually taken with meals to maximize its effectiveness and minimize gastrointestinal side effects. Consistent use and adherence to prescribed dosage are crucial for optimal results.\n\nIndications for Use\n\nType 2 Diabetes Mellitus: GLICLAGLAZE 80 is indicated for the management of type 2 diabetes in patients who cannot achieve adequate glycemic control through diet and exercise alone.\nCombination Therapy: It can be used in conjunction with other oral hypoglycemic agents or insulin to achieve better blood sugar control.\nSide Effects\nGLICLAGLAZE 80 is generally well-tolerated. However, some patients may experience side effects, including:\n\nHypoglycemia: Although less common, low blood sugar can occur, especially if meals are skipped or combined with excessive physical activity.\nGastrointestinal Issues: Nausea, abdominal pain, and diarrhea may occur but are usually mild and transient.\nAllergic Reactions: Rarely, allergic reactions such as skin rash, itching, or hives may occur.\nPrecautions and Contraindications\n\nLiver and Kidney Impairment: Patients with severe liver or kidney disease should use GLICLAGLAZE 80 with caution, as it may require dose adjustments.\nPregnancy and Lactation: Gliclazide is not recommended during pregnancy or breastfeeding. Alternative treatments should be considered.\nDrug Interactions: Inform your healthcare provider about all medications and supplements you are taking, as Gliclazide can interact with other drugs, potentially altering its effectiveness.\nConclusion\nGLICLAGLAZE 80 is a reliable and effective oral medication for managing type 2 diabetes mellitus. By stimulating insulin secretion, it helps control blood sugar levels, reducing the risk of diabetes-related complications. Its balanced approach to glycemic control, combined with potential cardiovascular benefits, makes GLICLAGLAZE 80 a valuable addition to diabetes management plans. Under the guidance of a healthcare professional, GLICLAGLAZE 80 can significantly improve the quality of life for individuals with type 2 diabetes, promoting better long-term health outcomes.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 265.0, "discountamount": 79.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "skin rash", "lower risk", "40 to 80 mg", "other drugs", "severe liver", "Reduced Risk", "Consistent use", "kidney disease", "abdominal pain", "excessive drops", "optimal results", "dose adjustments", "diabetic patients", "insulin secretion", "valuable addition", "Drug Interactions", "Kidney Impairment", "protective effect", "balanced approach", "Allergic Reactions", "healthcare provider", "Combination Therapy", "other sulfonylureas", "Blood Sugar Control", "target HbA1c levels", "overall heart health", "cardiovascular events", "cardiovascular system", "typical starting dose", "pancreatic beta cells", "Alternative treatments", "blood glucose response", "low blood sugar levels", "healthcare professional", "Gastrointestinal Issues", "type 2 diabetes mellitus", "diabetes management plans", "adequate glycemic control", "effective oral medication", "long-term health outcomes", "oral hypoglycemic therapy", "long-term glycemic control", "effective treatment option", "excessive physical activity", "optimal blood glucose levels", "gastrointestinal side effects", "diabetes-related complications", "other oral hypoglycemic agents", "other oral antidiabetic agents", "potential cardiovascular benefits" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1922, "imageuri": "https://productimages.withfloats.com/actual/668d2505c34ba6457aa3fb4d.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668d2505c34ba6457aa3fb4d.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-09T11:54:39.186Z", "updatedon": "2024-07-09T11:54:39.186Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/gliclaglaze-80-/1922", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLICLAGLAZE 80 ", "category": "DIABETIC RANGE", "tags": [ "Gliclazide 80mg side effects", "Gliclazide 80mg dosage", "Gliclazide 80mg Metformin 500mg", "Gliclazide 80mg price", "Gliclazide 80mg uses", "Gliclazide 80mg Uses in Hindi", "Gliclazide 80mg before or after meal" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "665ef948161afa2274ff25b9", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLICLAGALZE MR 60 ", "description": "GLICLAGALZE MR 60 \nGliclazide SR 60 mg\nIntroduction\nGLICLAGALZE MR 60 is an oral medication tailored for the treatment of Type 2 diabetes, featuring a 60 mg dose of Gliclazide in a sustained release (SR) formulation. This medication is designed to offer consistent control of blood sugar levels throughout the day, minimizing fluctuations and improving overall diabetes management.\n\nMechanism of Action\n\nGliclazide SR (60 mg): Gliclazide is a member of the sulfonylurea class of diabetes medications. It operates by stimulating the pancreatic beta cells to produce more insulin, a key hormone that helps lower blood glucose. The SR formulation allows for a gradual release of Gliclazide, maintaining a steady level of the drug in the bloodstream, which helps to prevent the peaks and troughs in blood sugar levels that can be problematic in diabetes management.\nBenefits\nGLICLAGALZE MR 60 is particularly beneficial for patients who need a moderate increase in their insulin production but are concerned about the risks of hypoglycemia associated with other diabetes treatments. The sustained release formulation ensures a more uniform effect over the day, which can lead to better adherence to treatment and overall patient satisfaction.\n\nDosage and Administration\n\nDosage: The dosage should be individualized based on the patient’s current treatment regimen, effectiveness, and tolerability. It is crucial to monitor blood glucose levels regularly to ensure optimal control and to adjust the dosage as needed.\nAdministration: This medication should be taken with food, ideally with the first main meal of the day. The tablet must be swallowed whole to maintain the integrity of the sustained release mechanism and ensure effective drug delivery.\nSide Effects\nCommon side effects of GLICLAGALZE MR 60 may include gastrointestinal disturbances such as nausea and upset stomach. There is also a risk of hypoglycemia, particularly if meals are skipped or delayed, or when combined with other glucose-lowering medications.\n\nConclusion\nGLICLAGALZE MR 60 offers a reliable and effective approach for managing Type 2 diabetes, providing a balanced and prolonged action to stabilize blood glucose levels. It supports a comprehensive diabetes management plan, which should include regular physical activity, diet modification, and routine monitoring of blood glucose. As with any medication regimen, it is important to consult with a healthcare provider to adjust the treatment according to individual health needs and response to therapy.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/gliclagalze-mr-60-133418\n\n\n\n\n\n", "price": 128.0, "discountamount": 38.4, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "food", "peaks", "risks", "upset", "meals", "Order", "EMAIL", "member", "nausea", "tablet", "stomach", "therapy", "troughs", "reliable", "response", "balanced", "Benefits", "patients", "integrity", "adherence", "60 mg dose", "Conclusion", "key hormone", "bloodstream", "information", "tolerability", "Introduction", "fluctuations", "sterispharma", "hypoglycemia", "sterisonline", "steady level", "effectiveness", "Gliclazide SR", "CALL/WHATSAPP", "uniform effect", "GLICLAGALZE MR", "SR formulation", "gradual release", "optimal control", "Type 2 diabetes", "oral medication", "first main meal", "prolonged action", "diet modification", "moderate increase", "blood sugar levels", "sulfonylurea class", "consistent control", "effective approach", "insulin production", "routine monitoring", "medication regimen", "Common side effects", "healthcare provider", "blood glucose levels", "diabetes medications", "pancreatic beta cells", "Administration Dosage", "effective drug delivery", "individual health needs", "current treatment regimen", "other diabetes treatments", "regular physical activity", "overall diabetes management", "sustained release mechanism", "overall patient satisfaction", "sustained release formulation", "gastrointestinal disturbances", "other glucose-lowering medications", "comprehensive diabetes management plan" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1293, "imageuri": "https://productimages.withfloats.com/actual/665ef94b480b81124f8647ec.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/665ef94b480b81124f8647ec.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T11:23:52.299Z", "updatedon": "2024-06-04T11:23:52.299Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/gliclagalze-mr-60-/1293", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLICLAGALZE MR 60 ", "category": "DIABETIC RANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "665ef0928da3a81d5c69e509", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLIBIMIDE 5 ", "description": "GLIBIMIDE 5 \nGlibenclamide (5 mg)\nGLIBIMIDE 5 is a medication containing Glibenclamide as its active ingredient, with each tablet containing 5 mg of the compound. Glibenclamide, also known as glyburide, belongs to the class of sulfonylurea medications and is commonly prescribed for the management of type 2 diabetes mellitus.\n\nAs a sulfonylurea, Glibenclamide works by stimulating the release of insulin from the pancreatic beta cells, thereby increasing insulin secretion. This mechanism of action helps to lower blood glucose levels by facilitating the uptake of glucose into cells for energy production and by reducing the production of glucose in the liver.\n\nGLIBIMIDE 5 is indicated for the treatment of type 2 diabetes mellitus in adults, particularly for patients whose blood sugar levels are not adequately controlled through lifestyle modifications alone. It is often prescribed as an adjunct to diet and exercise to improve glycemic control and prevent complications associated with uncontrolled diabetes.\n\nThe dosage of GLIBIMIDE 5 may vary depending on individual patient response and other factors such as age, renal function, and concurrent medications. It is typically administered orally once daily with breakfast or as directed by a healthcare professional.\n\nLike any medication, GLIBIMIDE 5 may cause side effects, including hypoglycemia (low blood sugar), gastrointestinal disturbances such as nausea or stomach upset, and allergic reactions in rare cases. Patients should be advised to monitor their blood sugar levels regularly and report any unusual symptoms to their healthcare provider.\n\nOverall, GLIBIMIDE 5 offers an effective option for the management of type 2 diabetes mellitus, providing patients with a convenient and reliable means of controlling their blood sugar levels. However, it should only be used under the guidance of a healthcare professional and as part of a comprehensive treatment plan that includes lifestyle modifications and regular monitoring of blood glucose levels.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/glibimide-5-133417\n\n\n", "price": 12.22, "discountamount": 3.66, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "5 mg", "diet", "part", "liver", "class", "EMAIL", "Order", "uptake", "adults", "dosage", "tablet", "nausea", "adjunct", "release", "compound", "exercise", "patients", "guidance", "GLIBIMIDE", "mechanism", "breakfast", "glyburide", "management", "rare cases", "convenient", "information", "side effects", "hypoglycemia", "sterispharma", "sterisonline", "CALL/WHATSAPP", "complications", "Glibenclamide", "other factors", "stomach upset", "renal function", "reliable means", "low blood sugar", "effective option", "glycemic control", "unusual symptoms", "active ingredient", "energy production", "insulin secretion", "allergic reactions", "regular monitoring", "blood sugar levels", "healthcare provider", "blood glucose levels", "uncontrolled diabetes", "pancreatic beta cells", "concurrent medications", "lifestyle modifications", "healthcare professional", "type 2 diabetes mellitus", "sulfonylurea medications", "individual patient response", "comprehensive treatment plan", "gastrointestinal disturbances" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1283, "imageuri": "https://productimages.withfloats.com/actual/665ef0944f159c14e15f2960.png", "tileimageuri": "https://productimages.withfloats.com/tile/665ef0944f159c14e15f2960.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T10:46:42.559Z", "updatedon": "2024-06-04T10:46:42.559Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glibimide-5-/1283", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIBIMIDE 5 ", "category": "DIABETIC RANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68b0256b813270ffac595cb0", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TRELAQWK 100", "description": "TRELAQWK 100 is an advanced oral antidiabetic medication containing Trelagliptin 100 mg, specifically designed for adults with type 2 diabetes mellitus (T2DM). Belonging to the class of Dipeptidyl Peptidase-4 (DPP-4) inhibitors, this formulation helps improve blood glucose control when used along with a proper diet and regular exercise.\nWith its once-weekly dosage regimen, TRELAQWK 100 offers a convenient treatment option, enhancing patient compliance and simplifying long-term diabetes management.\nKey Ingredient\nTrelagliptin 100 mg\nA long-acting DPP-4 inhibitor that regulates blood glucose levels by enhancing incretin hormones. These incretins stimulate insulin secretion and suppress glucagon release, helping to achieve better glycemic control.\nKey Benefits of TRELAQWK 100\nWeekly dosing ensures greater convenience and adherence\nReduces both fasting and postprandial blood sugar levels\nSupports natural blood sugar regulation without weight gain\nLow risk of hypoglycemia, especially when used as monotherapy or with non-insulin therapies\nCan be prescribed as monotherapy or in combination with other antidiabetic agents like metformin or sulfonylureas\nHow TRELAQWK 100 Works\nTRELAQWK 100 functions by blocking the DPP-4 enzyme, which normally degrades incretin hormones such as GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide).\nThese incretin hormones:\nStimulate insulin secretion in response to meals\nReduce glucagon release, lowering blood sugar levels\nThanks to its extended half-life, trelagliptin allows for once-weekly dosing, unlike other DPP-4 inhibitors that require daily administration.\nDirections for Use\nDosage: Take one tablet of TRELAQWK 100 once weekly, or as directed by your physician\nAdministration: May be taken with or without food, ideally on the same day each week\nMissed dose: Do not double the dose; consult your healthcare provider for guidance\nPossible Side Effects\nTRELAQWK 100 is usually well-tolerated, but some individuals may experience:\nMild headache\nNasopharyngitis (common cold-like symptoms)\nConstipation\nUpper respiratory tract infections\nRare skin allergies (rash, itching)\n👉 If you experience persistent abdominal pain, severe rashes, or symptoms suggestive of pancreatitis, stop the medication and seek medical care immediately.", "price": 550.0, "discountamount": 165.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2166, "imageuri": "https://productimages.withfloats.com/actual/68b0256ebb42c3d551ad314c.png", "tileimageuri": "https://productimages.withfloats.com/tile/68b0256ebb42c3d551ad314c.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-28T09:46:19.602Z", "updatedon": "2025-08-28T09:46:19.602Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/trelaqwk-100/2166", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "trelagliptin 100 mg", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68b02393f5434d48fca8b8ca", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TRELAQWK 50", "description": "TRELAQWK 50 is a modern oral antidiabetic tablet containing Trelagliptin 50 mg, specially developed for adults with type 2 diabetes mellitus. This once-weekly medication helps regulate blood sugar effectively, offering both convenience and strong clinical outcomes. With its advanced formulation, TRELAQWK 50 supports better glycemic control, making it easier for patients to lead a balanced and healthier lifestyle.\nManufactured under strict quality standards, TRELAQWK 50 ensures patient compliance, long-term safety, and efficacy in diabetes management.\nKey Ingredient\nTrelagliptin (50 mg):\nA unique, long-acting DPP-4 (dipeptidyl peptidase-4) inhibitor that allows weekly dosing, ensuring higher treatment adherence while maintaining effective control over blood glucose levels.\nKey Benefits of TRELAQWK 50\nProvides consistent blood sugar management with just one tablet per week\nEnhances insulin secretion while lowering glucagon levels in a glucose-dependent manner\nHelps reduce both fasting and postprandial blood glucose\nConvenient choice for patients with busy schedules who struggle with daily tablets\nLow risk of hypoglycemia when used as monotherapy\nSupports long-term improvement in HbA1c levels\nMechanism of Action – How TRELAQWK 50 Works\nTRELAQWK 50 works by blocking the DPP-4 enzyme, which normally degrades incretin hormones such as GLP-1 and GIP. These incretins are vital for maintaining blood sugar balance. By prolonging incretin activity, trelagliptin:\nStimulates insulin secretion from the pancreas\nReduces glucagon release from alpha cells\nHelps lower blood sugar, particularly after meals\nThis mechanism provides both effective glycemic control and improved patient compliance.\nDirections for Use\nTake one tablet of TRELAQWK 50 once a week, on the same day each week\nCan be taken with or without food\nSwallow whole with a glass of water\nFollow your doctor’s advice for dosage adjustment\nDo not double the dose if missed; consult your healthcare provider\nPossible Side Effects\nTRELAQWK 50 is usually well-tolerated. However, some patients may experience:\nMild headache\nNasopharyngitis (cold-like symptoms)\nDiarrhea\nStomach discomfort or indigestion\nRare allergic reactions (rash, itching)\nIf any unusual or persistent side effects occur, seek medical advice promptly.", "price": 375.0, "discountamount": 112.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2165, "imageuri": "https://productimages.withfloats.com/actual/68b023971624ba892ffd8c69.png", "tileimageuri": "https://productimages.withfloats.com/tile/68b023971624ba892ffd8c69.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-28T09:38:27.036Z", "updatedon": "2025-08-28T09:38:27.036Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/trelaqwk-50/2165", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "trelagliptin 50 mg", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6891f29bfb7044dfb2d43adf", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "MAGRAL 160", "description": "MAGRAL 160 is a pharmaceutical medication containing megestrol acetate 160 mg, a synthetic progestin known for its potent antineoplastic and appetite-stimulating properties. This drug is primarily prescribed to manage significant health challenges such as unexplained weight loss, anorexia, and cachexia, especially in patients suffering from chronic conditions like cancer or AIDS. Additionally, megestrol acetate functions as a hormone therapy agent employed in the treatment of certain hormone-sensitive malignancies. Its dual action both supports tumor management and improves patients' nutritional status by stimulating appetite and promoting weight gain, thereby enhancing overall quality of life. The drug is regarded as a crucial option in oncology and palliative care for managing complex conditions related to hormone-dependent cancers and severe wasting syndromes.\n\nWhat is MAGRAL 160?\nMAGRAL 160 is an oral medication formulated with megestrol acetate 160 mg, a synthetic progestin hormone derivative. It works primarily by modulating hormone receptors and altering hormone levels that influence the growth of hormone-responsive tumors such as breast and endometrial cancers. Apart from its antineoplastic action, it stimulates appetite by acting on the hypothalamic centers responsible for hunger, helping patients suffering from severe weight loss regain a healthy appetite and weight.\n\nUses of MAGRAL 160\n\nTo treat hormone-dependent cancers, specifically advanced breast cancer and endometrial cancer.\n\nTo stimulate appetite and promote weight gain in patients experiencing anorexia, cachexia, or unexplained severe weight loss related to chronic illnesses like cancer or AIDS.\n\nTo manage wasting syndromes that lead to malnutrition and significant weight loss.\n\nTo serve as an antineoplastic agent in hormone-sensitive malignancies.\n\nIn short, MAGRAL 160 is primarily used to treat anorexia and cachexia or serious unexplained weight loss and is also used as an antineoplastic agent to treat certain types of malignancy.\n\nSide Effects of MAGRAL 160\n\nWeight gain (often desirable but can be excessive)\n\nFluid retention and edema (swelling)\n\nNausea and vomiting\n\nDiarrhea or constipation\n\nVaginal bleeding or spotting in women\n\nFatigue, weakness, and insomnia\n\nHeadache and dizziness\n\nIncreased risk of blood clots (deep vein thrombosis or pulmonary embolism)\n\nHormonal imbalances, such as decreased sex hormone levels, which can lead to sexual dysfunction or bone density loss\n\nAllergic reactions including rash or itching\n\nPatients should report severe or unusual symptoms, especially signs of blood clots such as limb swelling, chest pain, or sudden shortness of breath, immediately to their healthcare provider.\n\nPrecautions before Using MAGRAL 160\n\nInform your doctor if you are pregnant, breastfeeding, or planning to conceive as MAGRAL 160 is contraindicated in pregnancy.\n\nDisclose any history of blood clots, cardiovascular diseases, liver or kidney impairment.\n\nPatients with diabetes should monitor blood sugar closely as megestrol acetate may cause hyperglycemia.\n\nAvoid sudden discontinuation without medical advice to prevent potential hormonal withdrawal effects.\n\nRegular monitoring is required, including hormone levels and blood tests, to assess efficacy and safety during treatment.\n\nUse cautiously in patients at risk for deep vein thrombosis or pulmonary embolism due to increased clotting risks.\n\nDrug Interactions: What Drugs Interact with MAGRAL 160?\n\nCYP3A4 enzyme inducers (e.g., rifampin, phenytoin) may reduce the effectiveness of megestrol acetate by increasing its metabolism.\n\nConcurrent use with blood thinners (anticoagulants) requires careful monitoring as MAGRAL 160 might influence clotting parameters.\n\nCombining with drugs that affect hormonal pathways, such as other hormonal therapies or corticosteroids, may alter treatment outcomes.\n\nInteractions with diabetes medications might necessitate dose adjustment due to potential effects on blood sugar control.\n\nCareful medical supervision is necessary when used with immunosuppressants or other chemotherapy agents to avoid additive side effects or altered drug levels.\n\nConclusion\nMAGRAL 160, containing megestrol acetate 160 mg, is a clinically validated medication widely used to manage complex conditions such as hormone-dependent cancers as well as severe weight loss due to anorexia and cachexia. Its unique ability to act both as an antineoplastic agent and an appetite stimulant makes it invaluable in improving patient outcomes, nutritional status, and overall quality of life. Patients prescribed MAGRAL 160 should adhere strictly to their healthcare provider’s instructions and report any adverse effects promptly. This medication should always be used under medical supervision to ensure optimal benefits and minimize risks.", "price": 810.0, "discountamount": 243.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2156, "imageuri": "https://productimages.withfloats.com/actual/6891f2a0115b51057b971998.png", "tileimageuri": "https://productimages.withfloats.com/tile/6891f2a0115b51057b971998.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-05T12:01:31.195Z", "updatedon": "2025-08-05T12:01:31.195Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/magral-160/2156", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "megestrol acetate 160 mg", "category": "Gynaecology", "tags": [ "megestrol acetate 160 mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6890aa548a215c65672372e1", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "EMPATECH LINA 25/5", "description": "EMPATECH LINA 25/5 is a pharmaceutical tablet containing a combination of two active ingredients: Empagliflozin 25MG and Linagliptin 5MG. This medication is designed to help manage blood sugar levels in adults with type 2 diabetes mellitus. The combination works through complementary mechanisms to improve glycemic control more effectively than either drug alone. Empagliflozin is a sodium-glucose cotransporter-2 (SGLT2) inhibitor that promotes the excretion of excess glucose through urine, while Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that enhances insulin secretion and suppresses glucagon release, particularly after meals. EMPATECH LINA 25/5 is generally prescribed alongside a balanced diet and regular exercise to optimize blood sugar management and reduce the risk of diabetes-related complications such as kidney damage, neuropathy, and cardiovascular issues.\n\nWhat is EMPATECH LINA 25/5?\n\nEMPATECH LINA 25/5 is a prescription medication combining Empagliflozin (25MG) and Linagliptin (5MG) tablets used to manage type 2 diabetes. It helps control elevated blood sugar levels by using dual actions — the removal of glucose via kidneys and improving pancreatic hormone responses. This combination aims to achieve better and sustained glycemic control, often necessary for patients who have inadequate blood sugar control with other treatments.\n\nUses of EMPATECH LINA 25/5\n\nTo improve blood sugar control in adults with type 2 diabetes, particularly when monotherapy is insufficient.\n\nOften used as a second-line therapy after metformin or when metformin is not tolerated.\n\nTo reduce HbA1c (hemoglobin A1c), an important measure of long-term glucose control.\n\nMay help reduce weight and blood pressure as empagliflozin aids in glucose excretion.\n\nSupports comprehensive diabetes management along with diet and exercise.\n\nPrevents or reduces the risk of diabetes-associated complications such as kidney disease, cardiovascular events, and nerve damage.\n\nSide Effects of EMPATECH LINA 25/5\n\nCommon side effects may include urinary tract infections and genital infections due to increased glucose in urine.\n\nIncreased urination and dehydration.\n\nDizziness or lightheadedness, especially when standing up quickly.\n\nHypoglycemia (low blood sugar), though rare with this combination.\n\nGastrointestinal symptoms such as nausea or diarrhea.\n\nPotential increased risk of ketoacidosis (a serious condition related to high blood acids) in rare cases.\n\nAllergic reactions, although uncommon, may occur and require prompt medical attention.\n\nPrecautions Before Using EMPATECH LINA 25/5\n\nInform your healthcare provider if you have kidney disease, liver problems, or a history of urinary tract infections.\n\nNot recommended for type 1 diabetes or diabetic ketoacidosis treatment.\n\nUse with caution if you are pregnant, planning to become pregnant, or breastfeeding.\n\nStay hydrated while on this medication to reduce the risk of dehydration and dizziness.\n\nInform your doctor about any history of pancreatitis or pancreas disorders.\n\nRegular monitoring of kidney function and blood sugar levels is advised during treatment.\n\nAvoid drinking excessive alcohol as it may increase side effects or risk of ketoacidosis.\n\nDrug Interactions: What Drugs Interact with EMPATECH LINA 25/5?\n\nOther antidiabetic medications, such as insulin or sulfonylureas, may increase the risk of hypoglycemia.\n\nDiuretics, blood pressure medications, and lithium may interact and increase side effects.\n\nDrugs that impair kidney function can affect empagliflozin’s efficacy and safety.\n\nCertain enzyme-inducing drugs may reduce linagliptin levels, lowering its effectiveness.\n\nConsult your healthcare provider for a full list of possible interactions and before starting any new medication, including over-the-counter drugs or supplements.\n\nConclusion\n\nEMPATECH LINA 25/5, containing Empagliflozin 25MG and Linagliptin 5MG, is an effective combination medication to treat high blood sugar levels caused by type 2 diabetes. Its dual-action approach targets different physiological mechanisms to improve blood glucose control, helping reduce the risks and complications associated with diabetes. While it is generally well-tolerated, awareness of possible side effects and drug interactions is important. Always use under medical supervision, alongside lifestyle modifications such as diet and exercise, for optimal diabetes management.", "price": 345.0, "discountamount": 104.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2154, "imageuri": "https://productimages.withfloats.com/actual/6890aa58dd0bc098c3220f4c.png", "tileimageuri": "https://productimages.withfloats.com/tile/6890aa58dd0bc098c3220f4c.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-04T12:40:52.619Z", "updatedon": "2025-08-04T12:40:52.619Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/empatech-lina-25-5/2154", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Empagliflozin and Linagliptin Tablets", "category": "DIABETIC RANGE", "tags": [ "Empagliflozin and Linagliptin Tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68723260f860f0528a938842", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "AMIPULSIDE CR 400", "description": "AMIPULSIDE CR 400 is a prescription-based, controlled-release formulation of Amisulpride 400 mg, developed to offer sustained therapeutic effects with once-daily dosing. Manufactured to high quality standards, this medication plays a vital role in the management of both acute and chronic schizophrenic disorders. It belongs to the class of atypical antipsychotics and works by regulating the activity of certain neurotransmitters in the brain, primarily dopamine. This helps control symptoms like hallucinations, delusions, disorganized thinking, and social withdrawal associated with schizophrenia.\n\nWhat is AMIPULSIDE CR 400?\nAMIPULSIDE CR 400 contains Amisulpride, a selective dopamine D2/D3 receptor antagonist. It is primarily used in the treatment of schizophrenia, particularly effective in managing both positive symptoms (e.g., hallucinations, delusions) and negative symptoms (e.g., emotional withdrawal, apathy). The controlled-release (CR) formulation allows for steady absorption and action, improving patient compliance and reducing fluctuations in symptom control.\n\nThis medication is designed for the treatment of acute and chronic schizophrenic disorders and is often used as part of a comprehensive psychiatric care plan, including counseling and behavioral therapy.\n\nUses of AMIPULSIDE CR 400\nManagement of acute episodes of schizophrenia\n\nLong-term maintenance therapy for chronic schizophrenic disorders\n\nEffective in treating positive symptoms (e.g., hallucinations, paranoia)\n\nBeneficial in alleviating negative symptoms (e.g., lack of motivation, social withdrawal)\n\nSide Effects of AMIPULSIDE CR 400\nLike all medications, AMIPULSIDE CR 400 may cause side effects in some patients. Common side effects include:\n\nInsomnia or drowsiness\n\nWeight gain\n\nConstipation\n\nAnxiety\n\nIncreased prolactin levels (can lead to breast tenderness or menstrual changes)\n\nTremors or stiffness (extrapyramidal symptoms)\n\nSerious but rare side effects may include:\n\nNeuroleptic malignant syndrome (fever, muscle rigidity, confusion)\n\nIrregular heart rhythms\n\nSeizures\n\nSeek immediate medical help if you experience chest pain, severe dizziness, or signs of an allergic reaction.\n\nPrecautions Before Using AMIPULSIDE CR 400\nBefore starting treatment with AMIPULSIDE CR 400, inform your doctor if:\n\nYou have a history of heart disease or irregular heart rhythms\n\nYou suffer from kidney or liver dysfunction\n\nYou are pregnant, planning pregnancy, or breastfeeding\n\nYou have Parkinson’s disease\n\nYou have low potassium or magnesium levels in your blood\n\nAvoid alcohol and other central nervous system depressants while taking this medication, as they may increase drowsiness or impair alertness.\n\nDrug Interactions\nAmisulpride can interact with a variety of medications, which may enhance or diminish its therapeutic effects or increase the risk of adverse events.\n\nWhat Drugs Interact with AMIPULSIDE CR 400?\nAntiarrhythmic drugs (e.g., quinidine, amiodarone): May increase the risk of heart rhythm abnormalities\n\nCNS depressants (e.g., benzodiazepines, opioids): Increase sedation and respiratory depression risk\n\nLevodopa and dopamine agonists: Can counteract the effect of Amisulpride\n\nSSRIs (e.g., fluoxetine, paroxetine): May increase the plasma levels of Amisulpride\n\nDrugs that prolong QT interval (e.g., erythromycin, haloperidol): May raise the risk of cardiac arrhythmias\n\nDiuretics: May alter electrolyte balance, increasing risk of heart rhythm disturbances\n\nAlways disclose all medications, supplements, or herbal products you are taking to your healthcare provider before starting AMIPULSIDE CR 400.\n\nConclusion\n\nAMIPULSIDE CR 400 (Amisulpride 400 mg CR Tablet) is a clinically effective medication for individuals suffering from schizophrenia, offering reliable symptom control through its controlled-release formulation. Its ability to treat both the acute and chronic phases of the disorder makes it a cornerstone in psychiatric management. Regular monitoring and adherence to prescribed guidelines ensure optimal results and improved quality of life for patients.", "price": 595.0, "discountamount": 179.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2145, "imageuri": "https://productimages.withfloats.com/actual/687232764d22e47aa874e361.png", "tileimageuri": "https://productimages.withfloats.com/tile/687232764d22e47aa874e361.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-07-12T10:01:04.938Z", "updatedon": "2025-07-12T10:01:04.938Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/amipulside-cr-400/2145", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "amisulpride tablet", "category": "NEUROLOGY RANGE", "tags": [ "Amisulpride" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "685d3aee734cdee72771a953", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "RIFAXEMANIA 200", "description": "RIFAXEMANIA 200 is a targeted intestinal antibiotic that contains Rifaximin 200 mg. This medication is widely used to treat gastrointestinal infections without affecting the rest of the body. Because of its poor absorption into the bloodstream, it works directly in the digestive tract, helping to treat infections like traveler’s diarrhea, IBS-D (Irritable Bowel Syndrome with Diarrhea), and complications related to liver conditions such as hepatic encephalopathy. RIFAXEMANIA 200 is formulated in tablet form, offering convenience, precision, and effective relief.\n\nWhat is Rifaximin 200 mg?\nRifaximin 200 mg is a non-systemic, semi-synthetic antibiotic derived from the rifamycin group. It functions by binding to bacterial RNA polymerase, preventing bacteria from multiplying. Since it stays confined to the gastrointestinal tract and is not absorbed significantly into the bloodstream, it’s ideal for treating localized gut infections.\n\nThis unique property makes the rifaximin 200 tablet suitable for conditions that do not require full-body antibiotic exposure, ensuring effective treatment with minimal side effects.\n\nUses of Rifaximin 200 Tablet\nRifaximin 200 mg is prescribed in tablet form to treat a variety of gut-related conditions. Common uses include the treatment of traveler’s diarrhea caused by non-invasive strains of E. coli, reducing the recurrence of hepatic encephalopathy in individuals with chronic liver disease, and relieving symptoms associated with IBS-D such as diarrhea, bloating, and abdominal pain.\n\nAdditionally, rifaximin is sometimes used to manage small intestinal bacterial overgrowth (SIBO), functional digestive disorders, and as part of combination therapy in certain inflammatory bowel conditions. These rifaximin 200 mg uses make it a valuable option for both acute and chronic digestive health management.\n\nSide Effects of Rifaximin 200 mg\nRifaximin is generally considered safe and well-tolerated due to its low systemic absorption. However, like all medications, some individuals may experience side effects. These can include nausea, abdominal pain, bloating, headache, constipation, or mild diarrhea. In rare cases, allergic skin reactions or fatigue may occur.\n\nMost of these effects are mild and temporary. If symptoms persist or worsen, it is advisable to contact a healthcare professional for further evaluation.\n\nPrecautions Before Using RIFAXEMANIA 200\nBefore using RIFAXEMANIA 200, patients should consider a few important precautions. Anyone with a known allergy to rifaximin or related antibiotics in the rifamycin class should avoid this medication. It should also be used cautiously in people with moderate to severe liver disease, as systemic absorption may be higher in such cases.\n\nPregnant or breastfeeding individuals should only use this product after consulting a physician. Rifaximin 200 mg is not recommended in cases of bloody diarrhea or fever, where a more systemic antibiotic may be required. Proper diagnosis and physician supervision are essential before starting treatment.\n\nDrug Interactions with Rifaximin 200 mg\nAlthough rifaximin is minimally absorbed into the bloodstream, it may still interact with certain medications, particularly in patients with liver impairment. For example, cyclosporine can significantly raise blood levels of rifaximin, requiring dose adjustments.\n\nOther drugs that may interact include warfarin (where INR monitoring is necessary), oral contraceptives (as effectiveness may decrease), and antiepileptic medications (which may have altered therapeutic effects). Always inform your doctor about all current medications, including over-the-counter supplements and herbal products, before starting rifaximin 200 tablet.\n\nWhy RIFAXEMANIA 200 is Recommended\nRIFAXEMANIA 200 offers precise and localized antibacterial action in the intestines without exposing the rest of the body to unnecessary drug effects. This makes it a preferred option for managing conditions like traveler’s diarrhea, hepatic encephalopathy, and IBS-D. Its convenient tablet form, reliable safety profile, and effectiveness in reducing symptoms make it a valuable part of modern gastrointestinal therapy.\n\nConclusion\nRIFAXEMANIA 200, containing Rifaximin 200 mg, is a clinically effective and safe treatment for bacterial infections limited to the gastrointestinal tract. With minimal absorption and a strong local antibacterial effect, it helps address common and chronic digestive conditions while minimizing adverse effects. Whether you are managing liver-related complications or looking for relief from persistent diarrhea and gut discomfort, RIFAXEMANIA 200 delivers dependable results.\n\nAlways follow your healthcare provider’s instructions for dosage and duration to ensure the best possible outcomes.\n\n", "price": 259.0, "discountamount": 78.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "rifaxemania 200", "rifaxemania 200 patients", "breastfeeding individuals", "valuable part", "current medications", "antiepileptic medications", "cases pregnant", "mild diarrhea", "effective relief", "rifaxemania 200rifaxemania 200", "rifaximin 200 mg", "persistent diarrhea", "safe treatment", "clinically effective", "preferred option", "herbal products", "overthecounter supplements", "oral contraceptives", "inr monitoring", "minimally absorbed", "physician supervision", "bloody diarrhea", "rifamycin class", "related antibiotics", "important precautions", "evaluation precautions", "welltolerated due", "valuable option", "combination therapy", "diarrhea bloating", "hepatic encephalopathy", "noninvasive strains", "tablet form", "absorbed significantly", "stays confined", "rifamycin group", "works directly", "poor absorption", "symptoms persist", "relieving symptoms", "liver impairment", "healthcare professional", "coli reducing", "complications related", "systemic absorption", "treat infections", "gastrointestinal tract", "minimal absorption", "managing conditions", "systemic antibiotic", "liver conditions", "reducing symptoms make", "treat gastrointestinal infections", "low systemic absorption", "managing liverrelated complications", "travelers diarrhea caused", "unique property makes", "minimal side effects", "chronic digestive conditions", "inflammatory bowel conditions", "gutrelated conditions common", "digestive tract helping", "healthcare providers instructions", "severe liver disease", "generally considered safe", "chronic liver disease", "targeted intestinal antibiotic", "minimizing adverse effects", "bacterial infections limited", "unnecessary drug effects", "altered therapeutic effects", "experience side effects", "helps address common", "localized antibacterial action", "required proper diagnosis" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2138, "imageuri": "https://productimages.withfloats.com/actual/685d3af25609b7ccc73e989b.png", "tileimageuri": "https://productimages.withfloats.com/tile/685d3af25609b7ccc73e989b.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-06-26T12:19:58.961Z", "updatedon": "2025-06-26T12:20:59.942Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/rifaxemania-200/2138", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "rifaximin 200", "category": "GASTROLOGYRANGE", "tags": [ "rifaximin 200", "rifaximin 200 mg uses in hindi", "rifaximin 200 mg uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }